Comerica Bank Sarepta Therapeutics, Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Comerica Bank holds 30,176 shares of SRPT stock, worth $4.16 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

30,176

Previous 34,207 11.78%

Holding current value

$4.16 Million

Previous $5.4 Million 30.27%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$124.33 - $156.75 $501,174 - $631,859	-4,031 Reduced 11.78%	30,176 $3.77 Million
Q2 2024 Aug 15, 2024	BUY	$113.33 - $163.85 $3.5 Million - $5.06 Million	30,871 Added 925.39%	34,207 $5.4 Million
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $259,549 - $392,038	2,770 Added 489.4%	3,336 $431,000
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $6.91 Million - $12.8 Million	-102,701 Reduced 99.45%	566 $54,000
Q3 2023 Nov 21, 2023	BUY	$102.5 - $123.59 $10.6 Million - $12.8 Million	103,267 New	103,267 $12.5 Million
Q4 2022 Jan 26, 2023	BUY	$100.86 - $132.13 $3.78 Million - $4.96 Million	37,502 Added 83.85%	82,228 $0
Q3 2022 Oct 28, 2022	BUY	$75.71 - $119.24 $3.39 Million - $5.33 Million	44,726 New	44,726 $4.95 Million
Q1 2021 Apr 28, 2021	SELL	$72.25 - $168.95 $2.11 Million - $4.95 Million	-29,270 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$125.56 - $178.74 $1.18 Million - $1.68 Million	9,422 Added 47.47%	29,270 $4.99 Million
Q3 2020 Oct 30, 2020	SELL	$127.12 - $172.34 $33,686 - $45,670	-265 Reduced 1.32%	19,848 $2.79 Million
Q2 2020 Jul 31, 2020	SELL	$93.0 - $171.7 $336,474 - $621,210	-3,618 Reduced 15.25%	20,113 $3.22 Million
Q1 2020 May 01, 2020	SELL	$82.38 - $131.64 $73,318 - $117,159	-890 Reduced 3.61%	23,731 $2.32 Million
Q4 2019 Feb 07, 2020	SELL	$76.53 - $135.58 $103,315 - $183,033	-1,350 Reduced 5.2%	24,621 $3.18 Million
Q3 2019 Oct 31, 2019	BUY	$72.81 - $156.91 $148,823 - $320,724	2,044 Added 8.54%	25,971 $1.96 Million
Q2 2019 Aug 02, 2019	SELL	$112.21 - $151.95 $48,362 - $65,490	-431 Reduced 1.77%	23,927 $0
Q1 2019 May 02, 2019	SELL	$106.67 - $151.68 $61,335 - $87,216	-575 Reduced 2.31%	24,358 $0
Q4 2018 Feb 06, 2019	BUY	$97.32 - $148.76 $503,436 - $769,535	5,173 Added 26.18%	24,933 $2.89 Million
Q3 2018 Nov 01, 2018	BUY	$115.31 - $161.51 $390,439 - $546,872	3,386 Added 20.68%	19,760 $2.65 Million
Q2 2018 Aug 01, 2018	BUY	$71.74 - $153.69 $12,339 - $26,434	172 Added 1.06%	16,374 $2.25 Million
Q1 2018 May 01, 2018	SELL	$54.02 - $82.27 $36,355 - $55,367	-673 Reduced 3.99%	16,202 $1.27 Million
Q4 2017 Feb 02, 2018	BUY	$47.64 - $56.75 $803,925 - $957,656	16,875	16,875 $1.11 Million

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $12.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account